Effects of RAL signal transduction in KRAS-and BRAF-mutated cells and prognostic potential of the RAL signature in colorectal cancer

B. Györffy, Iwona Stelniec-Klotz, Christian Sigler, Katharina Kasack, Torben Redmer, Yu Qian, Reinhold Schäfer

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Our understanding of oncogenic signaling pathways has strongly fostered current concepts for targeted therapies in metastatic colorectal cancer. The RALA pathway is novel candidate due to its independent role in controlling expression of genes downstream of RAS. We compared RALA GTPase activities in three colorectal cancer cell lines by GTPase pull-down assay and analyzed the transcriptional and phenotypic effects of transient RALA silencing. Knocking-down RALA expression strongly diminished the active GTP-bound form of the protein. Proliferation of KRAS mutated cell lines was significantly reduced, while BRAF mutated cells were mostly unaffected. By microarray analysis we identified common genes showing altered expression upon RALA silencing in all cell lines. None of these genes were affected when the RAF/MAPK or PI3K pathways were blocked. To investigate the potential clinical relevance of the RALA pathway and its associated transcriptome, we performed a meta-analysis interrogating progressionfree survival of colorectal cancer patients of five independent data sets using Cox regression. In each dataset, the RALA-responsive signature correlated with worse outcome. In summary, we uncovered the impact of the RAL signal transduction on genetic program and growth control in KRAS-and BRAF-mutated colorectal cells and demonstrated prognostic potential of the pathway-responsive gene signature in cancer patients.

Original languageEnglish
Pages (from-to)13334-13346
Number of pages13
JournalOncotarget
Volume6
Issue number15
Publication statusPublished - 2015

Fingerprint

Colorectal Neoplasms
Signal Transduction
GTP Phosphohydrolases
Cell Line
Genes
Microarray Analysis
Guanosine Triphosphate
Phosphatidylinositol 3-Kinases
Transcriptome
Meta-Analysis
Gene Expression
Survival
Growth
Neoplasms
Proteins
Datasets
Therapeutics

Keywords

  • Colon cancer
  • Progression free survival
  • Signal transduction

ASJC Scopus subject areas

  • Oncology

Cite this

Györffy, B., Stelniec-Klotz, I., Sigler, C., Kasack, K., Redmer, T., Qian, Y., & Schäfer, R. (2015). Effects of RAL signal transduction in KRAS-and BRAF-mutated cells and prognostic potential of the RAL signature in colorectal cancer. Oncotarget, 6(15), 13334-13346.

Effects of RAL signal transduction in KRAS-and BRAF-mutated cells and prognostic potential of the RAL signature in colorectal cancer. / Györffy, B.; Stelniec-Klotz, Iwona; Sigler, Christian; Kasack, Katharina; Redmer, Torben; Qian, Yu; Schäfer, Reinhold.

In: Oncotarget, Vol. 6, No. 15, 2015, p. 13334-13346.

Research output: Contribution to journalArticle

Györffy, B, Stelniec-Klotz, I, Sigler, C, Kasack, K, Redmer, T, Qian, Y & Schäfer, R 2015, 'Effects of RAL signal transduction in KRAS-and BRAF-mutated cells and prognostic potential of the RAL signature in colorectal cancer', Oncotarget, vol. 6, no. 15, pp. 13334-13346.
Györffy, B. ; Stelniec-Klotz, Iwona ; Sigler, Christian ; Kasack, Katharina ; Redmer, Torben ; Qian, Yu ; Schäfer, Reinhold. / Effects of RAL signal transduction in KRAS-and BRAF-mutated cells and prognostic potential of the RAL signature in colorectal cancer. In: Oncotarget. 2015 ; Vol. 6, No. 15. pp. 13334-13346.
@article{e79dc2d87ccf492392a2b9b92cc8f1ad,
title = "Effects of RAL signal transduction in KRAS-and BRAF-mutated cells and prognostic potential of the RAL signature in colorectal cancer",
abstract = "Our understanding of oncogenic signaling pathways has strongly fostered current concepts for targeted therapies in metastatic colorectal cancer. The RALA pathway is novel candidate due to its independent role in controlling expression of genes downstream of RAS. We compared RALA GTPase activities in three colorectal cancer cell lines by GTPase pull-down assay and analyzed the transcriptional and phenotypic effects of transient RALA silencing. Knocking-down RALA expression strongly diminished the active GTP-bound form of the protein. Proliferation of KRAS mutated cell lines was significantly reduced, while BRAF mutated cells were mostly unaffected. By microarray analysis we identified common genes showing altered expression upon RALA silencing in all cell lines. None of these genes were affected when the RAF/MAPK or PI3K pathways were blocked. To investigate the potential clinical relevance of the RALA pathway and its associated transcriptome, we performed a meta-analysis interrogating progressionfree survival of colorectal cancer patients of five independent data sets using Cox regression. In each dataset, the RALA-responsive signature correlated with worse outcome. In summary, we uncovered the impact of the RAL signal transduction on genetic program and growth control in KRAS-and BRAF-mutated colorectal cells and demonstrated prognostic potential of the pathway-responsive gene signature in cancer patients.",
keywords = "Colon cancer, Progression free survival, Signal transduction",
author = "B. Gy{\"o}rffy and Iwona Stelniec-Klotz and Christian Sigler and Katharina Kasack and Torben Redmer and Yu Qian and Reinhold Sch{\"a}fer",
year = "2015",
language = "English",
volume = "6",
pages = "13334--13346",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "15",

}

TY - JOUR

T1 - Effects of RAL signal transduction in KRAS-and BRAF-mutated cells and prognostic potential of the RAL signature in colorectal cancer

AU - Györffy, B.

AU - Stelniec-Klotz, Iwona

AU - Sigler, Christian

AU - Kasack, Katharina

AU - Redmer, Torben

AU - Qian, Yu

AU - Schäfer, Reinhold

PY - 2015

Y1 - 2015

N2 - Our understanding of oncogenic signaling pathways has strongly fostered current concepts for targeted therapies in metastatic colorectal cancer. The RALA pathway is novel candidate due to its independent role in controlling expression of genes downstream of RAS. We compared RALA GTPase activities in three colorectal cancer cell lines by GTPase pull-down assay and analyzed the transcriptional and phenotypic effects of transient RALA silencing. Knocking-down RALA expression strongly diminished the active GTP-bound form of the protein. Proliferation of KRAS mutated cell lines was significantly reduced, while BRAF mutated cells were mostly unaffected. By microarray analysis we identified common genes showing altered expression upon RALA silencing in all cell lines. None of these genes were affected when the RAF/MAPK or PI3K pathways were blocked. To investigate the potential clinical relevance of the RALA pathway and its associated transcriptome, we performed a meta-analysis interrogating progressionfree survival of colorectal cancer patients of five independent data sets using Cox regression. In each dataset, the RALA-responsive signature correlated with worse outcome. In summary, we uncovered the impact of the RAL signal transduction on genetic program and growth control in KRAS-and BRAF-mutated colorectal cells and demonstrated prognostic potential of the pathway-responsive gene signature in cancer patients.

AB - Our understanding of oncogenic signaling pathways has strongly fostered current concepts for targeted therapies in metastatic colorectal cancer. The RALA pathway is novel candidate due to its independent role in controlling expression of genes downstream of RAS. We compared RALA GTPase activities in three colorectal cancer cell lines by GTPase pull-down assay and analyzed the transcriptional and phenotypic effects of transient RALA silencing. Knocking-down RALA expression strongly diminished the active GTP-bound form of the protein. Proliferation of KRAS mutated cell lines was significantly reduced, while BRAF mutated cells were mostly unaffected. By microarray analysis we identified common genes showing altered expression upon RALA silencing in all cell lines. None of these genes were affected when the RAF/MAPK or PI3K pathways were blocked. To investigate the potential clinical relevance of the RALA pathway and its associated transcriptome, we performed a meta-analysis interrogating progressionfree survival of colorectal cancer patients of five independent data sets using Cox regression. In each dataset, the RALA-responsive signature correlated with worse outcome. In summary, we uncovered the impact of the RAL signal transduction on genetic program and growth control in KRAS-and BRAF-mutated colorectal cells and demonstrated prognostic potential of the pathway-responsive gene signature in cancer patients.

KW - Colon cancer

KW - Progression free survival

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=84931038337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931038337&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 13334

EP - 13346

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 15

ER -